|
Market Closed -
Oslo Bors
15:45:00 27/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 13.05 NOK | -2.61% |
|
+1.56% | -45.17% |
| 10-20 | Navamedic Extends Nordic Rights for Mysimba Obesity Drug | MT |
| 10-20 | Navamedic ASA Extends Mysimba Distribution Agreement With Azurity Pharmaceuticals | CI |
Chart: Technical Analysis
Oslo BorsNOK
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| NAVA | Real-time | |
CBOE
| NAVAo | Real-time | |
|
CBOE
| 0FDB | Real-time | |
|
Deutsche Boerse AG
| N1A | Delayed | |
|
Börse Stuttgart
| N1A | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Bearish |
| Resistance | 13.75 | 15.7 | 18.75 |
| Spread/Res. | -5.09% | -16.88% | -30.40% |
| Spread/Supp. | +3.57% | +3.57% | -1.51% |
| Support | 12.6 | 12.6 | 13.25 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NAVA Stock
- Charts Navamedic ASA
Select your edition
All financial news and data tailored to specific country editions
